medmk

Investigation of product derived lymphoma

Investigation of product derived lymphoma following infusion of piggyBac modified CD19 chimeric antigen receptor T-cells We carried out a Section I scientific trial of donor derived CD19-specific chimeric antigen receptor T-cells (CAR T-cells) for B-cell malignancy that relapsed or persevered after matched associated allogeneic hemopoietic stem cell transplant. To beat the fee and transgene capability limitations of conventional…

Read More